Influence of Creatinine Clearance on Survival Parameters in Small Cell Lung Cancer Treated with Cisplatin-Based Chemotherapy Regimen

被引：0
|
作者：
Gozel, Sedat [1 ]
Sumbul, Ahmet [1 ]
Sedef, Ali Murat [1 ]
Besen, Ayberk [1 ]
Mertsoylu, Huseyin [1 ]
Batmaci, Celal [2 ]
Kose, Fatih [3 ]
机构：
[1] Baskent Univ, Adana, Turkey
[2] Hakkari Devlet Hastanesi, Hakkari, Turkey
[3] Baskent Univ, Med Oncol, Adana, Turkey
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
creatinine clearance; small cell lung cancer; survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-010
引用
收藏
页码：S701 / S702
页数：2
相关论文
共 50 条
  • [31] Adjuvant or Induction Cisplatin-Based Chemotherapy for Operable Lung Cancer
    Besse, Benjamin
    Le Chevalier, Thierry
    ONCOLOGY-NEW YORK, 2009, 23 (06): : 520 - 527
  • [32] Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy
    Galsky, Matt D.
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Moshier, Erin L.
    Sonpavde, Guru
    Godbold, James H.
    Oh, William K.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    M B Polee
    W C J Hop
    T C Kok
    F A L M Eskens
    M E L van der Burg
    T A W Splinter
    P D Siersema
    H W Tilanus
    G Stoter
    A van der Gaast
    British Journal of Cancer, 2003, 89 : 2045 - 2050
  • [34] CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED TRIAL OF 3 CISPLATIN-BASED CHEMOTHERAPY REGIMENS
    HAINSWORTH, JD
    JOHNSON, DH
    HANDE, KR
    GRECO, FA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (04): : 345 - 349
  • [35] Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy
    Apolo, Andrea B.
    Ostrovnaya, Irina
    Halabi, Susan
    Iasonos, Alexia
    Philips, George K.
    Rosenberg, Jonathan E.
    Riches, Jamie
    Small, Eric J.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (07): : 499 - 503
  • [36] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    Polee, MB
    Hop, WCJ
    Kok, TC
    Eskens, FALM
    van der Burg, MEL
    Splinter, TAW
    Siersema, PD
    Tillanus, HW
    Stoter, G
    van der Gaast, A
    BRITISH JOURNAL OF CANCER, 2003, 89 (11) : 2045 - 2050
  • [37] Role of positron emission tomography in advanced stage non-small-cell lung cancer patients treated with cisplatin-based chemotherapy doublets
    Vittorio, G
    Ficola, U
    ANNALS OF ONCOLOGY, 2005, 16 : 308 - 308
  • [38] Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer
    Rosati, G
    Rossi, A
    Nicolella, G
    Panza, N
    ANTICANCER RESEARCH, 2000, 20 (3B) : 2229 - 2233
  • [39] Short Hydration Regimen with a Modified Dose of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy
    Hase, T.
    Miyazaki, M.
    Ichikawa, K.
    Yogo, N.
    Ozawa, N.
    Ando, M.
    Morise, M.
    Sato, M.
    Kondo, M.
    Yamada, K.
    Hasegawa, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S880 - S880
  • [40] Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
    Ma, Yu-Shui
    Hou, Li-Kun
    Yao, Shi-Hua
    Liu, Ji-Bin
    Yu, Xue-Chen
    Shi, Yi
    Yang, Xiao-Li
    Wu, Wei
    Wu, Chun-Yan
    Jiang, Geng-Xi
    Fu, Da
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 22 : 326 - 335
12345